Medtronic celebrates 40 years in IndiaFebruary 5, 2020
Medtronic India, the wholly-owned subsidiary of medical technology giant Medtronic Plc, celebrated 40 years of operations in India. The anniversary event was held in New Delhi on December 17 in the presence of key government officials, healthcare leaders, noted physicians, media, business partners and employees.
A book celebrating Medtronic’s 40-year journey of transforming healthcare in India was unveiled by leading physicians and surgeons and key government dignitaries at the event. The book showcases key milestones achieved by the company in India in its efforts to improving access to quality healthcare.
Healthcare experts and professionals convened to share their perspectives on the future of healthcare in India and the contribution of medical technology in improving patient outcomes.
“I am honoured to be leading Medtronic India during this milestone anniversary which is the celebration of an inspiring period of service to the health of India. We are proud of the innovative products and services launched in India and the outcomes that we’ve achieved”, said Madan Krishnan, Vice President and managing director, Medtronic India Sub-continent.
“Through our innovation-led, patient-centric and India-focused approach, we are confident of writing a golden chapter of winning India in the history of Medtronic. And most importantly, we continue to advance our mission and take healthcare further, together,” he added.
The book, ’40 Years of Transforming Healthcare in India’ includes some of the major turning points in Medtronic India’s journey from humble beginnings in 1979 in Vadodara (Baroda) with only 30 employees to a robust family of 1700 employees spanning 14 locations across India.
The book features two therapy and procedure training centres, two R&D centres and a global technology centre, which are a testament to Medtronic’s ever-increasing footprint in India, apart from introducing many world-class technologies and tailor-made solutions.
The book chronicles stories of patients, who were recipients of Medtronic therapies and healthcare professionals, through whom many of the key technologies were introduced into the market.